Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin

Generation of leukotrienes by purified human lung mast cells.

1982 • 302 citations

Human lung mast cells: purification and characterization.

1982 • 230 citations

Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

1983 • 205 citations

Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.

1976 • 75 citations

Bronchial responsiveness to acethylcholine in patients with bronchial asthma after long-term treatment with gold salt

1981 • 60 citations

The mechanism of basophil histamine release induced by pepstatin A.

1984 • 44 citations

Inhibition of IgE-Mediated Histamine Release from Human Basophils and Mast Cells by Fenoterol

1984 • 41 citations

Evidence for an adenosine A2/Ra receptor on human basophils

1985 • 36 citations

The Role of Basophils and Mast Cells in the Pathogenesis of Pulmonary Diseases

1985 • 36 citations

Auranofin therapy in rheumatoid arthritis.

1982 • 26 citations

Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophils

1984 • 18 citations

Gold-induced reduction in reactivity to histamine in isolated guinea pig tracheal rings

1983 • 13 citations

Biosynthesis and metabolism of leukotrienes.

1983 • 8 citations

Progress in clinical immunology : the role of chemical mediators and cellular interactions

1983 • 8 citations

Dimeric IgE may not represent the unit signal for the release of all mediators in human basophils

1984 • 6 citations